The key aim of the new EU Clinical Trial Regulation, which is
currently planned for implementation in mid-2019, is to boost clinical
research in the European Union (EU). Bruno Speder at SGS Clinical
Research discusses that the major impact will be a new authorisation
process which will involve a single submission via the EMA portal,
with a two-step approval procedure.